Kash Patel Did What? Did The Atlantic Publish Another Fake News Piece Again?
Good News: These Two Supreme Court Justices Are NOT Retiring
I'm Sure Republicans Were Happy to Hear This News Regarding Their 2026 Midterm...
Watch CNBC's Joe Kernen Wreck Hakeem Jeffries' Anti-Trump Talking Points Over the Economy
The Dems' Virginia Redistricting Push Still in Limbo As Election Day Nears
Look at Scott Jennings' Face When Kamala Harris Former Comms Director Said This...
Man Who Threw Molotov Cocktail at OpenAI CEO's Home Referenced Luigi Mangione
Iran Plays With Fire After Resuming Strait of Hormuz Blockade
Colorado's Religious Freedom Is a Rocky Mountain Lie
This Radio Chatter From the Iranian Attack on an Oil Tanker Is Crazy
ISIS Propagandist Who Called for 'Lone Wolf' Attacks Sentenced to 25 Years
The Iranians Are at It Again in the Strait of Hormuz
Deplorable Democrat Lawfare Just Came for This Trump Attorney
The End of the Charade: IOC Enforces Biology in Women's Sports and Restores...
Tipsheet

Trump Signs Executive Order to Fast-Track Psychedelic Treatments for Mental Illness

Trump Signs Executive Order to Fast-Track Psychedelic Treatments for Mental Illness
AP Photo/Jose Luis Magana

President Donald Trump has signed an executive order to speed the use of psychedelic drugs as a potential treatment for serious mental illness. 

The order directs the Food and Drug Administration to the Commissioner’s National Priority Vouchers to appropriate psychedelic drugs that have received breakthrough therapy designations for treating serious mental illnesses. 

Advertisement

That designation aims to ensure that people with serious mental illnesses, including veterans, can receive help. America’s veterans have a suicide rate of twice that of non-veterans. For over 20 years, there have been more than 6,000 veteran suicides per year.

The Order further directs the FDA and the Drug Enforcement Agency to establish a pathway for eligible patients to access investigational psychedelic drugs, including ibogaine compounds, that are under FDA review and that have met basic safety requirements under President Trump’s landmark Right to Try Act.

The Order requires the Secretary of Health and Human Services to allocate $50 million through the Advanced Research Projects for Health program to match investments made by state governments to advance research into psychedelic programs for populations with serious mental illness.

The HHS and FDA will collaborate with the Department of Veterans Affairs and the private sector to increase clinical trial participation and evidence generation surrounding experimental psychedelic therapies. 

The order tells the Attorney General to review these drugs upon successful completion of Phase 3 clinical trials so they can be rescheduled, if appropriate. 

Advertisement

Today, over 14 million American adults have a serious mental illness— a diagnosable mental, behavioral, or emotional disorder that substantially interferes with a person’s life and ability to function.


Advertisement



Editor’s Note: Do you enjoy Townhall’s conservative reporting that takes on the radical Left and woke media? Support our work so that we can continue to bring you the truth.

Join Townhall VIP and use promo code FIGHT to receive 60% off your membership.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement